A forward loop between glioma and microglia: Glioma-derived extracellular matrix-activated microglia secrete IL-18 to enhance the migration of glioma cells

Journal of Cellular Physiology

Volumn 227, Issue 2, 2012, Pages 558-568

  Yeh, Wei Lan ^a,b   Lu, Dah Yuu ^c   Liou, Houng Chi ^a   Fu, Wen Mei ^a,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL MUSEUM OF NATURAL SCIENCE   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; FIBRONECTIN; GUANYLATE CYCLASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 18; NITRIC OXIDE SYNTHASE INHIBITOR; VITRONECTIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; GLIOMA; GLIOMA CELL; IN VITRO STUDY; MICROFILAMENT; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PURIFICATION; RAT;

ACTIN CYTOSKELETON; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIC GMP; EXTRACELLULAR MATRIX; FIBRONECTINS; GENE EXPRESSION REGULATION; GLIOMA; INTERLEUKIN-18; MICROGLIA; NITRIC OXIDE; RATS; VITRONECTIN;

EID: 82155181745     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22746     Document Type: Article

References (56)

1. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. 2008. The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages. Crit Rev Oncol Hematol 66: 1-9.
2. Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A. 2007. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: A retrospective study. BMC Cancer 7: 156.
3. Badie B, Schartner JM. 2000. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery 46: 957-961 (discussion 961-952).
4. Balkwill F. 2004. Cancer and the chemokine network. Nat Rev Cancer 4: 540-550.
5. Balkwill F, Mantovani A. 2001. Inflammation and cancer: Back to Virchow? Lancet 357: 539-545.
6. Balkwill F, Charles KA, Mantovani A. 2005. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7: 211-217.
7. Baltrons MA, Garcia A. 1999. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells. J Neurochem 73: 2149-2157.
8. Bazan JF, Timans JC, Kastelein RA. 1996. A newly defined interleukin-1? Nature 379: 591.
9. Brown C, Pan X, Hassid A. 1999. Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: Relationship to microfilament dissociation and altered cell morphology. Circ Res 84: 655-667.
10. Condeelis J, Pollard JW. 2006. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 124: 263-266.
11. Cumberbatch M, Dearman RJ, Antonopoulos C, Groves RW, Kimber I. 2001. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism. Immunology 102: 323-330.
12. Dinarello CA. 2002. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 20: S1-S13.
13. Dinarello CA, Novick D, Puren AJ, Fantuzzi G, Shapiro L, Muhl H, Yoon DY, Reznikov LL, Kim SH, Rubinstein M. 1998. Overview of interleukin-18: More than an interferon-gamma inducing factor. J Leukoc Biol 63: 658-664.
14. Do TV, Symowicz JC, Berman DM, Liotta LA, Petricoin EF III, Stack MS, Fishman DA. 2007. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells. Mol Cancer Res 5: 121-131.
15. Egan RA, Vijayan VK. 1991. Fibronectin immunoreactivity in neural trauma. Brain Res 568: 330-334.
16. Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Buhrer C, Stahel PF. 2005. IL-18: A key player in neuroinflammation and neurodegeneration? Trends Neurosci 28: 487-493.
17. Giordano D, Magaletti DM, Clark EA. 2006. Nitric oxide and cGMP protein kinase (cGK) regulate dendritic-cell migration toward the lymph-node-directing chemokine CCL19. Blood 107: 1537-1545.
18. Graeber MB, Scheithauer BW, Kreutzberg GW. 2002. Microglia in brain tumors. Glia 40: 252-259.
19. Grivennikov S, Karin M. 2008. Autocrine IL-6 signaling: A key event in tumorigenesis? Cancer Cell 13: 7-9.
20. Grobben B, De Deyn PP, Slegers H. 2002. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 310: 257-270.
21. Jiang D, Ying W, Lu Y, Wan J, Zhai Y, Liu W, Zhu Y, Qiu Z, Qian X, He F. 2003. Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 3: 724-737.
22. Jiang GX, Zhong XY, Cui YF, Liu W, Tai S, Wang ZD, Shi YG, Zhao SY. 2010. Li CL. IL-6/STAT3/TFF3 signaling regulates human biliary epithelial cell migration and wound healing in vitro. Mol Biol Rep 37: 3813-3818.
23. John GR, Chen L, Rivieccio MA, Melendez-Vasquez CV, Hartley A, Brosnan CF. 2004. Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis. J Neurosci 24: 2837-2845.
24. Jung MK, Song HK, Kim KE, Hur DY, Kim T, Bang S, Park H, Cho DH. 2006. IL-18 enhances the migration ability of murine melanoma cells through the generation of ROI and the MAPK pathway. Immunol Lett 107: 125-130.
25. Karin M. 2006. Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436.
26. Kim J, Kim C, Kim TS, Bang SI, Yang Y, Park H, Cho D. 2006a. IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. Biochem Biophys Res Commun 344: 1284-1289.
27. Kim YJ, Hwang SY, Oh ES, Oh S, Han IO. 2006b. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways. J Neurosci Res 84: 1037-1046.
28. Kim YJ, Hwang SY, Hwang JS, Lee JW, Oh ES, Han IO. 2008. C6 glioma cell insoluble matrix components enhance interferon-gamma-stimulated inducible nitric-oxide synthase/nitric oxide production in BV2 microglial cells. J Biol Chem 283: 2526-2533.
29. Kohyama M, Saijyo K, Hayasida M, Yasugi T, Kurimoto M, Ohno T. 1998. Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18. Jpn J Cancer Res 89: 1041-1046.
30. Lin EY, Gouon-Evans V, Nguyen AV, Pollard JW. 2002. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 7: 147-162.
31. Lu DY, Liou HC, Tang CH, Fu WM. 2006. Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1alpha. Biochem Pharmacol 72: 992-1000.
32. Mahesparan R, Read TA, Lund-Johansen M, Skaftnesmo KO, Bjerkvig R, Engebraaten O. 2003. Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol 105: 49-57.
33. Mantovani A, Allavena P, Sica A, Balkwill F. 2008. Cancer-related inflammation. Nature 454: 436-444.
34. Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Kurimoto M. 1997. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Cancer Res 57: 4557-4563.
35. Milner R, Campbell IL. 2003. The extracellular matrix and cytokines regulate microglial integrin expression and activation. J Immunol 170: 3850-3858.
36. Murphy S. 2000. Production of nitric oxide by glial cells: Regulation and potential roles in the CNS. Glia 29: 1-13.
37. Netea MG, Kullberg BJ, Verschueren I, Van Der Meer JW. 2000. Interleukin-18 induces production of proinflammatory cytokines in mice: No intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. Eur J Immunol 30: 3057-3060.
38. Pelham RJ, Jr, Wang Y. 1997. Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc Natl Acad Sci USA 94: 13661-13665.
39. Piperi C, Zisakis A, Lea RW, Kalofoutis A. 2005. Role of cytokines in the regulation of glioma tumor growth and angiogenesis. Am J Immunol 1: 106-113.
40. Platten M, Kretz A, Naumann U, Aulwurm S, Egashira K, Isenmann S, Weller M. 2003. Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann Neurol 54: 388-392.
41. Rao JS. 2003. Molecular mechanisms of glioma invasiveness: The role of proteases. Nat Rev Cancer 3: 489-501.
42. Richman JG, Regan JW. 1998. Alpha 2-adrenergic receptors increase cell migration and decrease F-actin labeling in rat aortic smooth muscle cells. Am J Physiol 274: C654-C662.
43. Robinson-Smith TM, Isaacsohn I, Mercer CA, Zhou M, Van Rooijen N, Husseinzadeh N, McFarland-Mancini MM, Drew AF. 2007. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Cancer Res 67: 5708-5716.
44. Roggendorf W, Strupp S, Paulus W. 1996. Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol 92: 288-293.
45. Rosales AA, Roque RS. 1997. Microglia-derived cytotoxic factors. Part I: Inhibition of tumor cell growth in vitro. Brain Res 748: 195-204.
46. Safavi-Abbasi S, Wolff JR, Missler M. 2001. Rapid morphological changes in astrocytes are accompanied by redistribution but not by quantitative changes of cytoskeletal proteins. Glia 36: 102-115.
47. Sica A, Allavena P, Mantovani A. 2008. Cancer related inflammation: The macrophage connection. Cancer Lett 267: 204-215.
48. Sobel RA. 1998. The extracellular matrix in multiple sclerosis lesions. J Neuropathol Exp Neurol 57: 205-217.
49. Tang CH, Chen CF, Chen WM, Fong YC. 2011. IL-6 increases MMP-13 expression and cell motility in human chondrosarcoma cells. J Biol Chem 286: 11056-11066.
50. Venstrom KA, Reichardt LF. 1993. Extracellular matrix. 2: Role of extracellular matrix molecules and their receptors in the nervous system. FASEB J 7: 996-1003.
51. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA, Apte RN. 2003. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100: 2645-2650.
52. Watters JJ, Schartner JM, Badie B. 2005. Microglia function in brain tumors. J Neurosci Res 81: 447-455.
53. Weissenbach M, Clahsen T, Weber C, Spitzer D, Wirth D, Vestweber D, Heinrich PC, Schaper F. 2004. Interleukin-6 is a direct mediator of T cell migration. Eur J Immunol 34: 2895-2906.
54. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, Graf T, Pollard JW, Segall J, Condeelis J. 2004. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64: 7022-7029.
55. Yeh WL, Lu DY, Lee MJ, Fu WM. 2008. Leptin induces migration and invasion of glioma cells through MMP-13 production. Glia 57: 454-464.
56. Zhang SQ, Luo X, Huang HL, Chai Y, Hu DJ, Tao QS. 2010. [N-acetylcysteine antagonizes the Interleukin-18-induced expression of TNF-alpha and IL-6 in mouse vascular smooth muscle cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 26: 35-37.